Cryopyrin‐associated periodic syndrome with inflammatory bowel disease: A case study
Abstract Cryopyrin‐associated Periodic Syndrome (CAPS) is a rare, genetic autoinflammatory condition associated with NLRP3 gene mutations, causing upregulated innate immunity. CAPS manifests as systemic inflammation, causing a constellation of symptoms on a clinical spectrum of phenotypical severity...
Main Authors: | Karen N Raymond, Jonathan E D Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12523 |
Similar Items
-
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
by: Carolina Pellegrini, et al.
Published: (2018-12-01) -
Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases
by: Mikhail M. Kostik
Published: (2016-12-01) -
Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases
by: Beichu eGuo, et al.
Published: (2014-07-01) -
Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis Infliximab induce respuesta clínica, endoscópica e histológica en la colitis ulcerosa refractaria
by: F. Bermejo, et al.
Published: (2004-02-01) -
Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
by: Jang Wook Lee, et al.
Published: (2016-04-01)